0.5 mg/ml when reconstituted with 200 μl of deionised water
Buffer
50 mM Tris-HCl, pH 7.5, 500 mM NaCl, 0.1 % CHAPS; 6 % sucrose as stabilizer
Preservative
None
Storage
Store at 2-8°C
Reconstitution
Reconstitute lyophilized protein with 200 μl of deionised water
Introduction
Coronavirus is believed to cause a significant percentage of all common colds in human adults. Coronaviruses primarily infect the upper respiratory and gastrointestinal tract.
Keywords
Human coronavirus;coronavirus;HCoV;coronavirus OC43;HCoV OC43;HCoV-OC43;HCoV OC43 N;HCoV OC43 N protein
Citations
Publication ()
Have you cited DAGB101 in a publication? Let us know and earn a reward for your research.
Background
Human coronavirus OC43 (HCoV-OC43), along with other endemic coronaviruses such as HCoV-229E, HCoV-NL63, and HCoV-HKU1, is a common pathogen that primarily causes mild respiratory infections. HCoV-OC43 was first discovered through human embryonic tracheal organ culture and shares morphological features with avian infectious bronchitis virus. The HCoV-OC43 genome consists of single-stranded RNA encased in a helical nucleocapsid, and it encodes four structural proteins: spike protein (S), envelope protein (E), membrane protein (M), and nucleocapsid protein (N). While the genome structure and encoded proteins of HCoV-OC43 show significant similarities to those of SARS-CoV-2, the clinical symptoms of HCoV-OC43 are generally milder. Additionally, because HCoV-OC43 can be studied in lower biosafety level environments (BSL-2), it presents an attractive alternative model for SARS-CoV-2 research.
Figure 1. Comparison of Major Features between SARS-CoV-2 and HCoV-OC43 (Source: Kim MI, et al., 2023)
The clinical manifestations of HCoV-OC43 typically resemble those of the common cold, with symptoms such as fever and cough common in respiratory infections. While most infected individuals experience mild symptoms, high-risk groups—such as infants, the elderly, and immunocompromised individuals—may develop more severe respiratory infections, such as bronchiolitis and pneumonia. Although there is some correlation between HCoV-OC43 and neurological diseases like multiple sclerosis, this connection has not been fully validated. HCoV-OC43 infections are generally self-limiting, and compared to other coronaviruses like SARS-CoV-1 and MERS-CoV, the clinical severity of HCoV-OC43 is lower, making it a safer model for studying coronavirus infection mechanisms and vaccine development.
The evolutionary history of the HCoV-OC43 genome shows significant similarities to bovine coronavirus (BCoV), and HCoV-OC43 is believed to have originated from a spillover of BCoV. This cross-species transmission process and the adaptive mutations of HCoV-OC43 in the human population highlight its ongoing evolutionary capacity. The S protein region of HCoV-OC43 has undergone important evolutionary changes during its adaptation to human hosts, giving it unique characteristics in viral transmission and immune evasion. Despite differences in the mechanisms by which HCoV-OC43 and SARS-CoV-2 enter host cells, HCoV-OC43 still serves as a valuable model and reference for studying the biological properties of SARS-CoV-2 and for developing antiviral drugs.
Alternative Names
Human Coronavirus OC43 N Protein His Tag OC43 N Protein Recombinant Human Coronavirus OC43 N Protein Antigen Coronavirus OC43 N Protein HCoV-OC43 N Protein
References
1. Kim MI, et al. Human coronavirus OC43 as a low-risk model to study COVID-19. Viruses. 2023;15(2):578.
My Review for Recombinant HCoV-OC43 N protein [His]
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.